Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881283 · ClinicalTrials.gov registry record
Long-term Cardiovascular Risk in Cured Cushing's Patients
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 1
- Enrollment target
NCT00881283: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00881283 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881283 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-09-08 |
| Est. Completion | 2010-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00881283
The ClinicalTrials.gov registry entry for NCT00881283 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00881283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00881283 about?
NCT00881283 is a clinical study titled "Long-term Cardiovascular Risk in Cured Cushing's Patients". The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
What is the current status of trial NCT00881283?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2008-09-08. Estimated completion is 2010-03-30.
Who is sponsoring clinical trial NCT00881283?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.